Centrus Energy just locked in a new customer for the kind of nuclear fuel that barely existed as a commercial product a few years ago, and the end use is striking: compact reactors that could one day power U.S. Army bases and space missions.

The Ohio-based company announced on September 17 that it signed a multi-year contract to supply high-assay low-enriched uranium to Antares Nuclear, a company building microreactors for military and space applications. Deliveries are expected to start before 2030. Financial terms were not disclosed, but the deal includes upfront payments from Antares to help Centrus fund its production expansion.

What makes this fuel different

Standard nuclear fuel, the kind that powers commercial reactors across America, is uranium enriched to around 3 to 5 percent. High-assay low-enriched uranium is enriched to between 5 and 20 percent, which makes it far more energy-dense. That higher concentration is what allows next-generation reactors to be physically small, and smallness is exactly what the military and space programs need. You cannot ship a conventional nuclear plant to a forward operating base or a lunar outpost.

Antares was recently selected for the U.S. Army's Janus Program, a $2.2 billion initiative to build and operate microreactors on military bases. The ambition is that these units will eventually power remote installations that currently depend on diesel fuel, which has to be trucked in at enormous cost and risk. Space applications are a further horizon.

Why Centrus matters here

Centrus runs the only licensed high-assay low-enriched uranium production facility in the Western world, located in Piketon, Ohio. That monopoly position is not accidental. The fuel type was largely theoretical as a commercial product until recently, and Centrus spent years in a demonstration phase before transitioning toward commercial-scale production. The company launched a multi-billion-dollar expansion last year to increase output of both this fuel and conventional uranium.

The Antares deal adds to a backlog that Centrus reported at $4.5 billion as of the end of the second quarter. About $2.4 billion of that total sits under definitive agreements, not just letters of intent or contingent commitments, which gives the pipeline more credibility than a raw backlog figure typically suggests.

CEO Amir Vexler described the contract as confirmation that demand is "real and it is accelerating." That framing matters because the skeptical read on this market has always been that next-generation nuclear is perpetually five to ten years away. Binding, prepaid contracts are a different kind of evidence than roadmaps and press releases.

Still, the deal does not change Centrus' near-term financials in any measurable way. Deliveries do not begin until the back half of the decade, and because terms were not disclosed, there is no way to size the revenue contribution. The prepayments help with expansion costs, but the real payoff is years out.

The broader pattern is worth pausing on. The U.S. military has a documented interest in cutting its dependence on long fuel supply lines, which are expensive and dangerous in conflict zones. Nuclear microreactors are one credible answer to that problem. If the Janus Program moves forward at scale, and if space exploration accelerates through both NASA and commercial programs, demand for this specific fuel could grow significantly beyond what today's backlog captures. Centrus, sitting on the only Western production license, would be the primary beneficiary.

The question is whether the decade-long build-out required to meet that demand can be financed and executed before potential competitors find a way in, or before the programs themselves shift priorities. For now, prepayments from customers like Antares are doing part of the work of answering that question.